Cargando…

Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells

CUL4A encodes a core component of a cullin-based E3 ubiquitin ligase complex that regulates many critical processes such as cell cycle progression, DNA replication, DNA repair and chromatin remodeling by targeting a variety of proteins for ubiquitination and degradation. In the research described in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yunshan, Ma, Guangxin, Wang, Qin, Wen, Mingxin, Xu, Yangyang, He, Xiuquan, Zhang, Pengju, Wang, Yuli, Yang, Taomei, Zhan, Panpan, Wei, Guangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271407/ https://www.ncbi.nlm.nih.gov/pubmed/24368600 http://dx.doi.org/10.3390/molecules19010159

Ejemplares similares

CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR
por: Wang, Yunshan, et al.
Publicado: (2014)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2017)

Suppression of CUL4A attenuates TGF-β1-induced epithelial-to-mesenchymal transition in breast cancer cells
por: Wang, Yunshan, et al.
Publicado: (2023)

Cul3 substrate adaptor SPOP targets Nup153 for degradation
por: Ong, Joseph Y., et al.
Publicado: (2023)

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

Involvement of P-gp on Reversing Multidrug Resistance Effects of 23-Hydroxybetulinic Acid on Chemotherapeutic Agents
por: Liu, Zhihao, et al.
Publicado: (2021)

Cul-de-sac : roman /
por: Thériault, Yves
Publicado: (1981)

The Proto-Oncogene Int6 Is Essential for Neddylation of Cul1 and Cul3 in Drosophila
por: Rencus-Lazar, Sigal, et al.
Publicado: (2008)

Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas
por: Yan, Hong, et al.
Publicado: (2017)

CRL4A(DTL) degrades DNA-PKcs to modulate NHEJ repair and induce genomic instability and subsequent malignant transformation
por: Feng, Maoxiao, et al.
Publicado: (2021)

Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes
por: Yu, Qing, et al.
Publicado: (2020)

MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression in vitro
por: Xie, Yangmei, et al.
Publicado: (2018)

Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies
por: Xiu, Huiqing, et al.
Publicado: (2022)

LZTR1: A promising adaptor of the CUL3 family
por: Zhang, Hui, et al.
Publicado: (2021)

Stability of HIB-Cul3 E3 ligase adaptor HIB Is Regulated by Self-degradation and Availability of Its Substrates
por: Zhou, Zizhang, et al.
Publicado: (2015)

Pulse-SILAC and Interactomics Reveal Distinct DDB1-CUL4–Associated Factors, Cellular Functions, and Protein Substrates
por: Raisch, Jennifer, et al.
Publicado: (2023)

Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5
por: Sachs, Julia, et al.
Publicado: (2019)

A nonsense mutation in the CUL3 gene in a Chinese patient with autism spectrum disorder and epilepsy: A case report
por: Qian, Meijia, et al.
Publicado: (2022)

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination
por: Li, Ce, et al.
Publicado: (2019)

Substrate binding accelerates the conformational transitions and substrate dissociation in multidrug efflux transporter AcrB
por: Wang, Beibei, et al.
Publicado: (2015)

Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma
por: Wang, Chengxing, et al.
Publicado: (2022)

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells
por: Zhang, Lei, et al.
Publicado: (2022)

CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis
por: Xu, Junfen, et al.
Publicado: (2016)

Current trends of high-risk gene Cul3 in neurodevelopmental disorders
por: Lin, Ping, et al.
Publicado: (2023)

Natural flavonoids silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs
por: Ravikumar Reddy, D., et al.
Publicado: (2016)

CUL1 promotes trophoblast cell invasion at the maternal–fetal interface
por: Zhang, Q, et al.
Publicado: (2013)

Cul4A is an oncogene in malignant pleural mesothelioma
por: Hung, Ming-Szu, et al.
Publicado: (2011)

Characterization of Brassica rapa RAP2.4-Related Proteins in Stress Response and as CUL3-Dependent E3 Ligase Substrates
por: Mooney, Sutton, et al.
Publicado: (2019)

Cholinergic neurons in the basal forebrain are involved in behavioral abnormalities associated with Cul3 deficiency: Role of prefrontal cortex projections in cognitive deficits
por: Rapanelli, Maximiliano, et al.
Publicado: (2023)

CUL4B facilitates HBV replication by promoting HBx stabilization
por: Shan, Haixia, et al.
Publicado: (2022)

Pseudohypoaldosteronism Type II Caused by CUL3 Mutation Presented with Visual Impairment
por: Wang, Qiao, et al.
Publicado: (2018)

Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
por: Otsuka, Yukio, et al.
Publicado: (2023)

CUL4B increases platinum‐based drug resistance in colorectal cancer through EMT: A study in its mechanism
por: Luo, Jian‐Wu, et al.
Publicado: (2022)

CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression
por: Luo, Dakui, et al.
Publicado: (2023)

Frog intestinal perfusion to evaluate drug permeability: application to p-gp and cyp3a4 substrates
por: Yerasi, Neelima, et al.
Publicado: (2015)

CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases
por: Sharma, Puneet, et al.
Publicado: (2014)

Expression and purification of functional recombinant CUL2•RBX1 from E. coli
por: Diaz, Stephanie, et al.
Publicado: (2021)

Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3
por: Hu, Xiaoyan, et al.
Publicado: (2019)

Modification of Cul1 regulates its association with proteasomal subunits
por: Bloom, Joanna, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_adsk7pefvkbn752l194bgmphd9